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Available online xxxxCeramides are important for skinhealth,with amultitude of species found in both dermis and epidermis. The epi-
dermis contains linoleic acid-Ester-linked Omega-hydroxylated ceramides of 6-Hydroxy-sphingosine, Sphingo-
sine and Phytosphingosine bases (CER[EOH], CER[EOS] and CER[EOP], respectively), that are crucial for the
formation of the epidermal barrier, conferring protection from environmental factors and preventing trans-epi-
dermal water loss. Furthermore, a large number of ceramides, derivatives of the same sphingoid bases and var-
ious fatty acids, are produced by dermal and epidermal cells and perform signalling roles in cell functions ranging
from differentiation to apoptosis.
Supplementation with the n-3 polyunsaturated fatty acids (PUFA) eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) have shown promise as therapeutic agents in a number of inﬂammatory skin con-
ditions, altering the lipid proﬁle of the skin and production of bioactive lipids such as the eicosanoids,
docosanoids and endocannabinoids. In this study we wished to investigate whether EPA and DHA could also af-
fect the ceramide proﬁle in epidermis and dermis, and, in this way, contribute to formation of a robust lipid bar-
rier and ceramide-mediated regulation of skin functions.
Ex vivo skin explants were cultured for 6 days, and supplemented with EPA or DHA (50 μM). Liquid chromatog-
raphy coupled to tandem mass spectrometry with electrospray ionisation was used to assess the prevalence of
321 individual ceramide species, and a number of sphingoid bases, phosphorylated sphingoid bases, and phos-
phorylated ceramides, within the dermis and epidermis.
EPA augmented dermal production ofmembers of the ceramide families containingNon-hydroxy fatty acids and
Sphingosine or Dihydrosphingosine bases (CER[NS] and CER[NDS], respectively), while epidermal CER[EOH],
CER[EOS] and CER[EOP] ceramides were not affected. DHA did not signiﬁcantly affect ceramide production. Cer-
amide-1-phosphate levels in the epidermis, but not the dermis, increased in response to EPA, but not DHA.
This ex vivo study shows that dietary supplementation with EPA has the potential to alter the ceramide proﬁle of
the skin, and this may contribute to its anti-inﬂammatory proﬁle. This has implications for formation of the epi-
dermal lipid barrier, and signalling pathways within the skinmediated by ceramides and other sphingolipid spe-
cies. This article is part of a Special Issue entitled: Membrane Lipid Therapy: Drugs Targeting Biomembranes
edited by Pablo Escríba-Ruíz.
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1.1. Skin physiology is supported by distinct lipid metabolism
The skin is the largest organ of the body and functions as a barrier
preventing water loss and entry of harmful compounds or organisms
from the environment, as well as offering protection against solar radi-
ation [1]. It also allows sensations of pain, temperature and touch, con-
tributes to thermoregulation, and mediates inﬂammatory and immune
responses. The skin is characterised by active lipid metabolism, with a
distinct proﬁle of lipids, and is the source of an array of bioactive lipid
mediators [2].
Skin is composed of threemain layers, the dermis, the epidermis and
the hypodermis, and because of its protective function, is continuously
dynamic. Epidermal keratinocytes differentiate as they migrate up-
wards, eventually becoming corneocytes. These protein-enriched
corneocytes are embedded in a lipid-rich matrix comprising a large
number of ceramide species, cholesterol and free fatty acids, to form
the stratum corneum [3,4]. Also found in the epidermis are the anti-
gen-presenting Langerhans cells and pigment-producing melanocytes
[2]. The dermis contains a number of important structures (small
blood vessels and nerves, hair follicles and sweat glands) together
with dermal ﬁbroblasts and immune cells, all enclosed within collagen
and elastic ﬁbres [2,5]. The subcutaneous tissue (hypodermis) that
forms the lowest of the skin layers contains blood vessels and adipo-
cytes sufﬁcient in number to form adipose tissue. Although adipose tis-
sue has its major role as a lipid storage site, it is also a source of fatty
acid-derived lipid mediators with signalling properties [6]. Sebum-de-
rived lipids are found on the surface of the skin; this complex mixture
of triacylglycerols, diacylglycerols, non-esteriﬁed fatty acids, wax esters,
squalene and cholesterol esters offer photoprotection and exert anti-
microbial activities, although the entire spectrum of its role is not yet
fully understood [7,8].
Importantly, it has been shown that epidermal keratinocytes have
very low desaturase activity, resulting in poor ability to form long
chain polyunsaturated fatty acids (PUFA), including arachidonic acid
(AA; 20:4n-6) [9]. This highlights the importance of systemic long
chain PUFA supplementation for skin health, and the role of dermal-epi-
dermal cross talk for the efﬁcient structure and function of the epider-
mis. Indeed, the essential fatty acid linoleic acid (LA; C18:2n-6) is of
particular signiﬁcance to skin health, as it contributes to the formation
of ceramides essential for the structure of the epidermal barrier [3],
and the absence of LA-containing ceramides in the stratum corneum re-
sults in barrier permeability problems [10–12].
As well as contributing to the structural integrity of the skin, PUFA
such as LA, AA, eicosapentaenoic acid (EPA; C20:5n-3) and
docosahexaenoic acid (DHA; C22:6n-3) are metabolized to
octadecanoids, eicosanoids, docosanoids, endocannabinoids and related
bioactive lipid species, known to mediate inﬂammatory and immune
reactions in many tissues, including skin [13–17].
1.2. Sphingolipids perform unique roles within the skin
Comprising both signalling and structural lipids, the cutaneous
sphingolipids are crucial for skin health. Sphingoid bases, ceramides
and their phosphorylated derivatives have been analysed, and hundreds
identiﬁed in skin [18–24]. Whilst the functions of the signalling
sphingolipid species in other mammalian tissues continue to be eluci-
dated [25], knowledge of their function in skin is rather sparse [26].
However, the role of structural ceramides in forming the skin barrier
is better understood.
As discussed, the barrier function of the skin depends on the pres-
ence of a speciﬁc mixture of lipids within the intercellular spaces of
the stratum corneum [27]. Towards the end of the keratinocyte differen-
tiation process, synthesised lipids that have accumulated in lamellar
granules are discharged and released by the action of enzymes co-Please cite this article as: A.C. Kendall, et al., Lipid functions in skin: Differen
in a human skin organ cul..., Biochim. Biophys. Acta (2017), http://dx.doi.secreted from the lamellar bodies (including phospholipases,
sphingomyelinase and β-glucocerebrosidase) [4,28]. These are the
main source of the barrier lipids, and diseases with changes in activity
of such enzymes give rise to abnormal barrier function (e.g [29].). Barri-
er lipids represent about 10% of the mass of the stratum corneum, and
consist of about 50% ceramides, 25% cholesterol and 15% non-esteriﬁed
fatty acids [30–32]. The composition and organisation of these lipids has
been discussed recently by van Smeden et al. [33].
The ceramides are of particular importance, and display extreme
complexity due to a multitude of substructures comprising different
sphingoid bases and fatty acids (see Fig. 1 for ceramide families, includ-
ing structures and an explanation of the nomenclature) including some
very long chain N-acyl fatty acids. Notably, there is a sub-group of
ceramides that contain LA esteriﬁed to the omega carbon of omega-hy-
droxy fatty acids (CER[EOS], CER[EODS], CER[EOP] and CER[EOH]; Fig. 1).
These are found solely in the epidermis and help to form themultilayers
of membrane sheets, crucial for skin barrier function [20].
In essential fatty acid deﬁciency, there is an abnormal appearance of
the extracellular lipid membrane that is commensurate with impaired
barrier function, which reﬂects failure to synthesise these ceramide
families [34,35]. The important role of LA in barrier function is discussed
by Elias et al. [3]. Additionally, changes in individual ceramide propor-
tions have a noticeable effect on barrier conformation and, hence, its
properties [36].
1.3. n-3PUFA supplementation and skin sphingolipids
The importance of PUFA in skin health is clear, especially the poten-
tial beneﬁts of n-3PUFA supplementation, which has been shown in
several studies to ameliorate some inﬂammatory skin conditions [15,
37–40]. Additionally, the crucial role of ceramides in maintaining a
healthy epidermal barrier has been thoroughly examined.
Ex vivo skin organ culture has long been used as a model system for
the assessment of skin physiology and is a useful system for the study of
skin lipids [41,42]. Organ culture systems similar to the one used in this
study have shown that skin can be kept viable for up to 4weeks [43–46]
and maintain physiological processes including irritant-induced
Langerhans cell migration [47], and release of inﬂammatory mediators
including eicosanoids, endocannabinoids, interleukin-1 and histamine
[16,48,49].
Previously, our group has explored the PUFA-derived bioactive lipids
present in human epidermis and dermis, and reported the presence of a
range of prostanoids, hydroxy fatty acids, endocannabinoids and N-acyl
ethanolamides [16]. Using ex vivo skin as a means of manipulating the
cutaneous fatty acid proﬁle under controlled conditions, we showed
that provision of EPA or DHA through the culture media perturbed
some existing lipid mediators and also gave rise to anti-inﬂammatory
lipid species in both the dermis and the epidermis [16]. In the present
study, we wished to expand this analysis and examine the effect of n-
3PUFA supplementation on the ceramide proﬁle of the skin, aiming to
explore whether n-3PUFA have the potential to affect the formation
and integrity of the barrier through changes in the main lipid compo-
nent of the epidermis - structural ceramides - as well as signalling
members of the sphingolipid family found in both the epidermis and
dermis.
2. Materials and methods
2.1. Materials
Cell culture reagents, fatty acids and LC/MS grade solvents were pur-
chased fromSigmaAldrich (Poole, UK). Calciumchloridewas purchased
from Promocell (Heidelberg, Germany). Internal standard cocktail (Cer-
amide/Sphingoid Internal Standard Mixture I) was purchased from
Avanti Polar Lipids, Alabaster, Alabama, USA).tial effects of n-3 polyunsaturated fatty acids on cutaneous ceramides,
org/10.1016/j.bbamem.2017.03.016
Fig. 1. The ceramides are a complex family of sphingoid-based lipids. Nomenclature of the different ceramide families is based on the sphingoid base (sphingosine, S; dihydrosphingosine
(also known as sphinganine), DS; phytosphingosine, P; 6-hydroxysphingosine; H) and fatty acid (non-hydroxy, H; alpha-hydroxy, A; ester-linked omega-hydroxy, EO). Different
combinations of sphingoid base and fatty acid generate the different ceramide families, for example a non-hydroxy fatty acid (N) amide-linked to a sphingosine (S) base creates a
CER[NS] ceramide. Individual ceramide species are further identiﬁed by carbon chain lengths of both base and fatty acid. For example, an NS ceramide with a 30-carbon non-hydroxy
fatty acid and a 20-carbon sphingosine base is denoted as N(30)S(20). The above ceramide families have all been identiﬁed in human skin [21].
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Skin was obtained from the Ethical Tissue biobank (University of
Bradford, Bradford, UK) with full ethical approval (Leeds East Research
Ethics Committee reference 07/H1306/98+5). Skin was obtained with
informed consent from four healthy female donors (33–47 years;
white Caucasian), who were undergoing elective abdominoplasty sur-
gery. Samples were delivered to the biobank within 1 h of surgery,
and then to the laboratory within 12 h of this (refrigerated if overnight
storage was necessary).2.3. Ex vivo skin organ culture
Skin tissue was washed in PBS containing 100 U/ml penicillin, 100
μg/ml streptomycin and 2.5 mg/ml amphotericin B, and the adipose
layer was removed. Punch biopsies (6 mm diameter) were cut from
the tissue, and cultured in 24-well plates with 500 μl DMEM (supple-
mented with 100 U/ml penicillin, 100 μg/ml streptomycin and 1.4 mM
Ca2+) as previously reported [16]. The Ca2+ (1.4 mM) was added in
the form of CaCl2, directly to the media. Exogenous calcium has been
shown tomaintain keratinocyte and ﬁbroblast survival in full-thickness
human skin [41,50,51]. Fatty acid supplementation was performed by
dissolving EPA or DHA inDMSO and adding this (2 μl per 10mlmedium,
or an equal volume of vehicle (DMSO)) directly to the media to a ﬁnal
concentration of 50 μM. Fatty acid treatments were prepared and re-
placed daily, for a total of 6 days of culture. A concentration of 50 μM
EPA/DHAwas chosen as we have found this to be sufﬁcient to alter cel-
lular fatty acid levels without a risk of toxicity in epidermal keratinocyte
and dermal ﬁbroblast monolayers (unpublished data). Lack of toxicity
at this dose has also been published previously [52–54]. In the present
study, the viability of skin tissue and lack of toxicity of the fatty acid sup-
plement were assessed via analysis of lactate dehydrogenase (LDH)Please cite this article as: A.C. Kendall, et al., Lipid functions in skin: Differen
in a human skin organ cul..., Biochim. Biophys. Acta (2017), http://dx.doi.release, usingmedia removed from the culture wells each day (LDH Cy-
totoxicity Assay Kit; Cayman Chemical, Ann Arbor, USA) (Supplementa-
ry data S3). EPA/DHA uptake was conﬁrmed by GC-FID analysis (1
punch biopsy, 120–250 mg), as previously described [55] (Supplemen-
tary data S3). After 6 days in culture, skin biopsies were washed in PBS,
snap-frozen and stored at−80 °C for lipidomic analysis.
2.4. Analysis of lipids by UPLC/ESI-MS/MS
Skin (1 punch biopsy per time point, 120–250mg) was divided into
dermis and epidermis by scalpel at ×40 magniﬁcation, and lipids were
extracted as previously described [16,17]. Although a scalpel does not
produce a completely clean separation of the dermis and epidermis,
and some dermal contamination of the epidermis remains, this method
prevents any degradation of the lipids that occurs during other separa-
tion techniques that depend on incubation in salts, enzymes or extreme
temperatures [56,57], and care was taken not to allow any epidermal
contamination of the dermis.We have previously shown this technique
to reveal clear differences in the lipid proﬁles of the two skin compart-
ments [16]. Dermal tissue weighed 100–200 mg, while epidermal sec-
tions weighed 20–55 mg. Tissue was homogenised in ice-cold
isopropanol:water:ethyl acetate (30:10:60; v/v/v; 4 ml per sample)
using a blade homogeniser (X10/25 drive with 10 mm diameter shaft,
set at a speed of 11 kHz; Ystral, Ballrechten-Dottingen, Germany) for 3
× 3 s pulses, on ice. Internal standardswere added (a cocktail containing
50 pmol each of C17 S, C17 DS, C17 S1P, C17DS1P, C12 C1P and C25 Cer)
and the samples were incubated on ice for 90 min. Samples were
centrifuged to remove protein precipitate and the supernatant was
dried down under nitrogen, before lipid extracts were reconstituted in
methanol with 0.1% (v/v) formic acid.
Lipidomic analysis was performed using ultraperformance liquid
chromatography (Acquity UPLC; Waters, Wilmslow, UK) coupled to a
triple quadrupole mass spectrometer with electrospray ionisationtial effects of n-3 polyunsaturated fatty acids on cutaneous ceramides,
org/10.1016/j.bbamem.2017.03.016
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C8 column (Acquity UPLC BEH, 1.7 μm, 2.1 × 100 mm; Waters,
Wilmslow, UK) and a gradient of solvent A (water with 0.1% formic
acid) and solvent B (methanol with 0.1% formic acid) at a ﬂow rate of
0.3 ml/min as follows: 60% B (0–6 min), 60–96% B (6–9 min), 96–
100% B (9–20 min), 100% B (20–30 min), 100–60% B (30–32 min),
60% B (32–40min). Analyteswere fragmented using argon as a collision
gas and monitored in the positive ion mode by multiple reaction moni-
toring (MRM) (parameters given in Supplementary data S1). Relative
quantiﬁcation of analytes was performed using the class-speciﬁc inter-
nal standards described above.
2.5. Protein content
Following tissue homogenisation and extraction of the lipids from
the biopsies, the protein precipitate was collected and the protein con-
tent measured using Bio\\Rad Protein Assay II [58] (Bio\\Rad, Hemel
Hempstead, UK).
2.6. Statistical analysis
Friedman tests followed by Dunn's multiple comparisons tests for
differences in ceramide and lipid mediator expression were performed
using GraphPad Prism version 7.00. P b 0.05 was considered signiﬁcant.
3. Results
3.1. Ceramide species from 11 families were identiﬁed in skin explants
Using UPLC/ESI-MS/MS we measured the prevalence of 321 cer-
amide species from 11 different families in the dermis and epidermis
of ex vivo skin explants (Fig. 2). These comprised 57 CER[NS], 75
CER[NDS], 30 CER[NH], 39 CER[NP], 23 CER[AS], 28 CER [ADS], 19
CER[AH], 20 CER[AP], 10 CER[EOS], 8 CER[EOP] and 12 CER[EOH] cer-
amide species (Supplementary data S2). Of these, only 16 dermal spe-
cies (6 CER[NDS], 2 CER[AS], 1 CER[ADS] and 7 CER[AH]) and 15
epidermal species (6 CER[NDS], 2 CER[AS], 1 CER[ADS] and 6 CER[AH])
were below the limit of detection. As expected, the CER[EOS], CER[EOH]
and CER[EOP] families were only found in the epidermis, while all otherFig. 2. Ceramide species from 11 different families were identiﬁed in human dermis and epide
using a C8 column, and identiﬁed using a triple-quadrupole mass spectrometer with electrospr
time.
Please cite this article as: A.C. Kendall, et al., Lipid functions in skin: Differen
in a human skin organ cul..., Biochim. Biophys. Acta (2017), http://dx.doi.families were found in both the dermis and epidermis, although the
proportions of ceramide families did vary between the two skin com-
partments (Fig. 3A).
Following supplementation of the ex vivo skin explants with EPA or
DHA (50 μMfor 6 days), the ceramides showed some changes in expres-
sion, which were more apparent in the dermis than the epidermis (Fig.
3B). Although therewas no statistically signiﬁcant difference in the total
ceramide pool, or the totals of the 11 ceramide families (data not
shown), there were differences in individual ceramide species.
3.2. CER[NS] and CER[NDS] ceramides increase in the dermis in response to
EPA supplementation
Following EPA supplementation, expression of nine CER[NS] and 13
CER[NDS] species was found statistically signiﬁcantly increased in the
dermis (Fig. 4). These CER[NS] and CER[NDS] species were
N(25)S(24), N(30)S(20), N(26)S(24), N(24)S(26), N(30)S(21),
N(28)S(23), N(26)S(25), N(25)S(26) and N(28)S(24), and
N(24)DS(24), N(22)DS(26), N(29)DS(20), N(28)DS(21),
N(27)DS(22), N(26)DS(23), N(25)DS(24), N(24)DS(25),
N(30)DS(20), N(28)DS(22), N(26)DS(24), N(24)DS(26), and
N(26)DS(25), respectively. These changeswere not observed in the epi-
dermis, where EPA hadno signiﬁcant effect on CER[NS] or CER[NDS] cer-
amide expression. Although there was a trend for increased CER[NS] in
the dermis and epidermis, and CER[NDS] expression in the dermis, fol-
lowing DHA supplementation, this did not reach statistical signiﬁcance.
Therewas considerable variation between skin donors in their response
to EPA or DHA supplementation.
3.3. Levels of other ceramide families did not change in the dermis or epi-
dermis in response to n-3PUFA supplementation
The LA-containing CER[EOS], CER[EOH] and CER[EOP] families were
present only in the epidermis (Fig. 3), and there was no overall trend
in response to EPA or DHA supplementation, and no signiﬁcant change
in any of the individual species measured in our assay.
The other ceramide families (CER[NH], CER[NP], CER[AS], CER[ADS],
CER[AH], and CER[AP]) showed no signiﬁcant change in expression fol-
lowing supplementation with EPA or DHA, in the dermis or epidermis.rmis. Analytes were separated by reverse-phase ultraperformance liquid chromatography
ay ionisation. Identiﬁcation was performed bymultiple reaction monitoring and retention
tial effects of n-3 polyunsaturated fatty acids on cutaneous ceramides,
org/10.1016/j.bbamem.2017.03.016
Fig. 3.Matched skin samples from four donors were cultured, with or without EPA or DHA supplementation (50 μM) for 6 days. Skin was separated into dermis and epidermis and the
ceramide expression was quantiﬁed by UPLC/ESI-MS/MS. The proportions of ceramide families were different in the dermis and epidermis (A). Data shown are from control samples,
as % of total ceramides detected. The skin showed some changes in sphingolipid expression following supplementation with EPA or DHA (B). Data are shown as the mean log2 fold
change compared with control samples of four donors. Grey boxes represent missing data (no expression in control or treated samples).
5A.C. Kendall et al. / Biochimica et Biophysica Acta xxx (2017) xxx–xxxAgain there was variation between skin donors but no consistent in-
crease or decrease following fatty acid supplementation (Fig. 3).
3.4. Sphingoid bases and phosphorylated species
The 18 carbon sphingosine (S) and dihydro-sphingosine (DS) bases
and sphingosine-1-phosphate (S1P) were present in the dermis and
epidermis, but showed no change in expression following EPA or DHA
supplementation (Fig. 5). DS1P was present only in concentrations
around the limit of detection.
3.5. Phosphorylated ceramide species
Wemeasured four different ceramide-1-phosphate (C1P) species in
the dermis and epidermis in control skin and following supplementa-
tion with EPA or DHA (Fig. 5). Two of these species, N(16)S(18)C1PPlease cite this article as: A.C. Kendall, et al., Lipid functions in skin: Differen
in a human skin organ cul..., Biochim. Biophys. Acta (2017), http://dx.doi.andN(18)S(18)C1Pwere themost abundant, and showed a clear statis-
tically signiﬁcant upregulation in EPA-treated epidermis comparedwith
control or DHA-treated epidermis (Fig. 5). There was no difference in
C1P levels in the dermis following n-3 supplementation.
4. Discussion
The importance of dietary fatty acids for skin health has long been
known [59,60]. N-3PUFA supplementation has been shown to be bene-
ﬁcial for skin health [2,15,37,40], and since ceramides are crucial in nor-
mal skin function, we were interested in whether manipulation of the
skin's fatty acid proﬁle following n-3PUFA treatmentwould have an im-
pact on ceramide production in the dermis and epidermis.We have pro-
ﬁled 321 ceramide species in human dermis and epidermis using a
semi-quantitative UPLC/ESI-MS/MS method [16]. Identiﬁcation of indi-
vidual ceramide species by fragmentation pattern and retention timetial effects of n-3 polyunsaturated fatty acids on cutaneous ceramides,
org/10.1016/j.bbamem.2017.03.016
Fig. 4. CER[NS] and CER[NDS] ceramide species in the dermis and epidermis following supplementationwith EPA andDHA.Data are shown as log2 fold changes from control,mean±SEM
of four skin donors. *P b 0.05 vs control.
6 A.C. Kendall et al. / Biochimica et Biophysica Acta xxx (2017) xxx–xxxhas allowed us to perform relative quantiﬁcation using internal stan-
dards [18,19,21]. This analysis includes CER[NS], CER[NDS], CER[NH],
CER[NP], CER[AS], CER[ADS], CER[AH] and CER[AP] species that may
have roles in inter-cellular signalling, as well as CER[EOS], CER[EOH]
and CER[EOP] species that are crucial for successful epidermal barrierPlease cite this article as: A.C. Kendall, et al., Lipid functions in skin: Differen
in a human skin organ cul..., Biochim. Biophys. Acta (2017), http://dx.doi.formation [4,26]. In addition, we have examined some of the related
bioactive lipid mediators, including S1P and C1P species known to
have signalling roles within the skin [26,61,62].
Several species of CER[NS] and CER[NDS] showed increased expres-
sion in the dermis, but not epidermis, in response to EPA. The ceramidetial effects of n-3 polyunsaturated fatty acids on cutaneous ceramides,
org/10.1016/j.bbamem.2017.03.016
Fig. 5. Sphingoid bases, S1Ps andC1Ps in thedermis and epidermis following supplementationwith EPA andDHA.Data are shown as log2 fold changes from control,mean±SEM. *P b 0.05
vs control.
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dant of the CER[NS] and CER[NDS] families (Supplementary data S2).
Analysis of ceramide family totals showed no signiﬁcant differences fol-
lowing EPA supplementation (data not shown), and the increases were
speciﬁc to these low-abundance species. This indicates the response is
not an artefactual ﬁnding due to low basal amounts of these species. Al-
though a similar trend was observed with DHA supplementation, this
did not reach statistical signiﬁcance for any ceramide species. This was
due to variation in the responses of skin from different donors, and is
supported by previous reports on inter-individual variation in the up-
take and response to n-3PUFA [63]. The n-3PUFA-induced increases
were not seen with any of the other ceramide families, and overall, we
observed that the skin's ceramide proﬁle was largely unaffected by pro-
vision of EPA or DHA. To date, we have been unable to ﬁnd any reports
on the effect of EPA and DHA on ceramides throughout the dermis and
epidermis, and this absence of global ceramide changes may highlight
the complexity of ceramide metabolism in the skin.
Previous studies on the inﬂuence of n-3PUFA on ceramides in tissues
other than skin show tissue-dependent responses. In murine muscle
cells, EPA or DHA added independently at a concentration of 50 μM
have both been shown to impair a palmitate-induced increase in
CER[NS] [64], whilst in vivo dietaryﬁsh oil supplementation (which con-
tains EPA and DHA together) inmice can inhibit a high-fat-diet-induced
CER[NS] increase in skeletal muscle [65]. It has also been shown in
humans that adopting a Nordic diet (which includes high ﬁsh consump-
tion), leads to reduction in some plasma CER[NS] ceramides, although
the originating tissue of these species is unknown [66]. This variation
between tissue responses is evident within the same animal, as mice
on ﬁsh oil- or krill oil-supplemented diets had decreased CER[NS] and
CER[NDS] ceramides in the liver, and increased CER[NS] and CER[NDS]
ceramides in the brain [67]. Increased ceramide production has also
been seen in breast cancer cells following EPA or DHA supplementation
in vitro, or ﬁsh oil supplementation in vivo, through increased neutral
sphingomyelinase activity [68].
Given the signalling roles of CER[NS] and CER[NDS] species, their re-
ported increase in the dermis in response to EPA supplementation may
contribute to regulation of ﬁbroblast functions, such as cell differentia-
tion and apoptosis [26]. However, since the identiﬁcation of individual
ceramide species is a relatively recent development in lipidomics,Please cite this article as: A.C. Kendall, et al., Lipid functions in skin: Differen
in a human skin organ cul..., Biochim. Biophys. Acta (2017), http://dx.doi.there is little evidence for the roles of speciﬁc ceramides, and we have
been unable to ﬁnd any previous studies on the individual CER[NS]
and CER[NDS] species we found to be altered by EPA. As the ﬁeld ad-
vances, we expect studies to be performed using individual ceramide
species, which may elucidate their roles.
The involvement of sphingomyelinase is a possible explanation for
our ﬁndings. Increased sphingomyelinase activity would lead to the in-
creased release of ceramides stored in membrane sphingomyelins (Fig.
6). However, sphingomyelinase is known to release both CER[NS] and
CER[AS] ceramides from sphingomyelins, in the stratum corneum at
least [69], and CER[AS] ceramides remained unaltered by n-3PUFA sup-
plementation in our study. We have previously shown that EPA, and its
metabolite docosapentaenoic acid, can downregulate neutral
sphingomyelinase and ceramide expression in rat brain [70]. DHA has
previously been shown to downregulate ceramide release from
sphingomyelins in retinal endothelial cells through a downregulation
of acid sphingomyelinase [71]. However, the ceramide proﬁle of the
skin is unique and the effect of n-3PUFA on sphingomyelinases in the
skin may be different.
Another potential store of ceramides in the skin is the
glucosylceramides (Fig. 6). Although CER[NS] have been identiﬁed as
being part of glucosylceramides in the epidermis, CER[NDS] ceramides
have not to date [72]. The inﬂuence of n-3PUFA on the activity of
glucosylceramidases, the enzymes that release ceramides from the
glucosylceramides, is not known, and further studies would be needed
to explore if increased glucosylceramidase activity could explain the in-
crease of only CER[NS] and CER[NDS] species, as observed in our study.
Inhibition of the uptake of ceramides into sphingomyelins or
glucosylceramides could also explain our ﬁndings, although the regula-
tion of these processes in skin is not yet understood [69,72]. Overall, the
impact of n-3PUFA on cutaneous sphingomyelins and
glucosylceramides merits further investigation, as effects on the activity
of speciﬁc sphingomyelinases or glucosylceramidases in our study can-
not be ruled out.
A possiblemechanismof increased ceramide production could be an
effect on de novo ceramide biosynthesis (Fig. 6). CER[NDS] ceramides
are produced upstream of other ceramides, and initially converted
into CER[NS] species. DHA, but not EPA, has been found to block west-
ern-diet-induced upregulation of de novo ceramide synthesis in thetial effects of n-3 polyunsaturated fatty acids on cutaneous ceramides,
org/10.1016/j.bbamem.2017.03.016
Fig. 6. The sphingolipid cycle allows ceramides to bemetabolized through various pathways, including de novo synthesis, presence in sphingomyelins or glucosylceramides, or production
of phosphorylated signalling species. There are multiple potential targets through which n-3PUFA could alter ceramide levels.
8 A.C. Kendall et al. / Biochimica et Biophysica Acta xxx (2017) xxx–xxxliver, by blocking the induction of serine-palmitoyl transferase long
chain base subunit-1 [73], but the unique sphingolipid metabolism in
the skin could lead to different responses compared with other tissues.
The absence of any change in CER[AS], CER[ADS], CER[AH] or CER[AP]
ceramides is notable, since it indicates that only ceramides containing a
non-hydroxy fatty acid are affected by short-term n-3PUFA supplemen-
tation. There is evidence that n-3PUFA preferentially displace certain
fatty acids from cell membranes, and ceramide-speciﬁc changes might
be related to this [74]. Previous studies on the effect of n-3PUFA on
ceramides in tissues other than skin have focussed on CER[NS] and
CER[NDS] species [64,65,67], and so more studies are needed to explore
this. The levels of epidermal CER[EOS], CER[EOH] and CER[EOP]
ceramides were not altered either. These ceramide families are crucial
in the formation of the epidermal barrier in the stratum corneum, and
are unique in their requirement for LA [20]. LA deﬁciency results in sub-
stitution with oleic or other fatty acids instead [75]. Our results suggestPlease cite this article as: A.C. Kendall, et al., Lipid functions in skin: Differen
in a human skin organ cul..., Biochim. Biophys. Acta (2017), http://dx.doi.that short-term n-3PUFA supplementation did not affect the availability
of linoleic acid for continued synthesis of these species. However, since
we have used a targeted approach to measure ceramides in this assay,
we only evaluated a ﬁxed panel of ceramide species. This means there
could be new species formed following EPA or DHA supplementation
that we did not identify. Examples of new species could include acyl-
ceramides containing alpha-linolenic acid (ALA) instead of LA, should
EPA or DHA undergo retroconversion to ALA (which has previously
been observed in the blood [76]) in a similarmanner that AA can under-
go retroconversion to LA in the skin [77].
While we observed no change in the sphingoid bases or phosphory-
lated sphingoid bases measured following n-3PUFA supplementation,
an increase in epidermal, although not dermal, C1P species following
EPA treatment was noted. C1P species are synthesised from ceramides
by ceramide kinase [61]. As we did not measure a signiﬁcant increase
in epidermal precursor ceramides, our ﬁndings could be attributed totial effects of n-3 polyunsaturated fatty acids on cutaneous ceramides,
org/10.1016/j.bbamem.2017.03.016
9A.C. Kendall et al. / Biochimica et Biophysica Acta xxx (2017) xxx–xxxincreased ceramide kinase activity. Such enhanced activity could also
explain the lack of increased levels of ceramides in the EPA-treated epi-
dermis, as metabolism to C1P species would negate their accumulation
(Fig. 6). Increased levels of C1P in the epidermis could have an anti-in-
ﬂammatory effect, stimulating cell proliferation and migration, and
inhibiting apoptosis [26,61].
A valuable aspect of this study was the independent assessment of
EPA and DHA, two n-3PUFA that are often considered together in nutri-
tional studies (e.g. assessing intake of ﬁsh or ﬁsh oil). The different re-
sponse of skin sphingolipids to EPA and DHA support the notion that
their action relates to formation of speciﬁc lipid mediators, rather than
n-3PUFA-related changes in membrane composition. For example, the
endocannabinoid receptor CB1 is linked to ceramide synthesis through
sphingomyelin hydrolysis and de novo synthesis [78], and we have pre-
viously shown that supplementation of ex vivo skinwith EPA or DHA in-
creased production of the endocannabinoid anandamide, as well as the
EPA- and DHA-derived congeners [16]. Indeed, in an earlier study using
the same ex vivo organ culture model we found that following just
3 days of supplementation with EPA or DHA the skin started to produce
EPA- and DHA-derived eicosanoid and N-acyl ethanolamide species, re-
spectively, in both the dermis and epidermis. This indicates that not
onlywas the skin able to take up the PUFA and distribute them through-
out the skin, but also metabolise the EPA and DHA into signalling com-
pounds [16].
The different responses of the dermis and epidermis reported in this
study could indicate compartmental differences in lipid metabolism.
Whilst CER[NS] and CER[NDS] ceramides were increased in the dermis
but not epidermis in response to EPA (Fig. 4), C1P species were in-
creased in the epidermis but not the dermis (Fig. 5). In the skin organ
culture method employed in this study, n-3PUFA supplementation
was through the dermis that was submerged in culture medium, repli-
cating the in vivo support of the epidermis. Skin was harvested after
6 days in culture, which we have previously shown is sufﬁcient for
dermal and epidermal uptake and metabolism of supplementary n-
3PUFA [16] (and shown in Supplementary data S3). Therefore, differ-
ences in enzyme expression between the two skin compartments
could contribute to different responses to n-3PUFA, although to-date
the epidermis has been studied far more extensively than the dermis,
and no comprehensive comparison of sphingolipid enzyme expression
is available.
In light of differences seen in this study, an important aspect is the
examination of the dermis and epidermis separately. We believe that
this is the ﬁrst investigation of the full ceramide proﬁle and comparison
of both skin layers. The different responses of the main skin compart-
ments to n-3PUFA supplementation reveal the importance of studying
full-thickness skin, since cross-talk and communication between the
epidermal and dermal layers could have signiﬁcant roles to play in
skin health and disease [79]. The differences are highlighted when the
proportions of ceramide families are comparedwith those found in pre-
vious studies that focussed on the stratum corneum [21]. Whilst tape-
stripping of the stratum corneum is a useful, non-invasive sampling
technique that allows analysis of the surface ceramides, it does not accu-
rately reﬂect the proﬁle of the dermis and epidermis, and biopsy sam-
pling is the best approach to study full-thickness skin ceramides.
Overall, this ex vivo study has implications for our understanding of
the role of n-3PUFA in skin health. The implications of EPA-induced cer-
amide changes in the skin should be explored further, and studies are
needed to directly assess other aspects of skin physiology in this skin
organ culture model following EPA supplementation, since we limited
our analysis to ceramide proﬁling. Whilst the skin organ culture system
attempts to replicate the systemic delivery and metabolism of n-3PUFA
in the epidermis and dermis, clinical studies with dietary supplementa-
tion are needed to conﬁrm whether their effects on cutaneous
ceramides are reproducible in vivo, and allow the detailed examination
of the impact of longer-term dietary supplementation on skin lipid
biology.Please cite this article as: A.C. Kendall, et al., Lipid functions in skin: Differen
in a human skin organ cul..., Biochim. Biophys. Acta (2017), http://dx.doi.Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2017.03.016.
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